Showing 5881-5890 of 10734 results for "".
Acne Scars: Optimizing Treatment with Devices and Combinations
https://practicaldermatology.com/topics/practice-management/acnescarsoptimizingtreatmentwithdevicesand-combinations/20542/Multiple factors affect the selection of a treatment for acne scars. Best outcomes are possible with a combination of approaches.Advancing Sexual Health Histories in Dermatology: A Modernized Comprehensive Approach for Diverse Populations
https://practicaldermatology.com/topics/feature/advancing-sexual-health-histories-in-dermatology-a-modernized-comprehensive-approach-for-diverse-populations/28864/According to the CDC’s 2022 STI Surveillance Report, sexually transmitted infections (STIs) have seen a 1.9% increase in diagnoses over the past five years, underscoring a persistent public health challenge.Total Body Skin Exams: Don't Abandon Them
https://practicaldermatology.com/topics/skin-cancer-photoprotection/total-body-skin-exams-dont-abandon-them/20628/Lesion-directed exams may save time, but is the limited temporal savings worth it?Prednisone-induced DRESS Syndrome
https://practicaldermatology.com/topics/general-topics/prednisone-induced-dress-syndrome/21572/This unusual reaction was resolved with a switch to a Group C steroid.The Clinical Significance of Gene Expression Profile Testing for Melanoma
https://practicaldermatology.com/topics/practice-management/the-clinical-significance-of-gene-expression-profile-testing-for-melanoma/20647/Accumulated evidence on GEP Classification suggests that it provides clinically relevant information that can influence patient management for the better.Social Distancing and Increased Sun Exposure: A Resource For Patients
https://practicaldermatology.com/topics/skin-cancer-photoprotection/social-distancing-and-increased-sun-exposure-a-resource-for-patients/23391/As patients continue to favor outdoor events, it’s essential they protect their skin.Navigating Practice: Tips from the DEF Webinar Series
https://practicaldermatology.com/conferences/conference-coverage-def/navigating-practice-tips-from-the-def-webinar-series/23301/From skin signs of COVID-19 to strategies for optimizing telehealth, experts shared strategies to support NPs and PAs.EHR User Series—Part III
https://practicaldermatology.com/topics/practice-management/ehr-user-seriespart-iii/21509/A Q&A series with clinicians about their experience and broader impressions of EHRs in dermatology.Advanced Management Solutions for High-Grade Cutaneous Toxicities to Cancer Therapy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/advanced-management-solutions-for-high-grade-cutaneous-toxicities-to-cancer-therapy/57176/The emergence of immune checkpoint inhibitors (ICIs) has fundamentally altered the prognosis for patients with advanced skin malignancies, yet the high incidence of cutaneous immune-related adverse events (irAEs) remains a significant barrier to treatment continuity. Here, we review the clinical manSelecting the Optimal JAK Inhibitor for Alopecia Areata
https://practicaldermatology.com/topics/hair-nails/selecting-the-optimal-jak-inhibitor-for-alopecia-areata/67265/Since 2022, the US Food and Drug Administration (FDA) has approved three oral JAK inhibitors: baricitinib, ritlecitinib, and deuruxolitinib.